Microplastics Safety Act
- Bill Number
- S. 2353
- Origin Chamber
- Senate
- Congress
- 119th Congress, Session 1
- Policy Area
- Health
- Status
- Introduced
- Latest Action
- 2025-07-17: Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
- Last Updated
- 2025-12-05T21:45:56Z
AI-Generated Summary
Purpose
The Microplastics Safety Act aims to assess the risks posed by microplastics—tiny plastic particles—in everyday food and water sources. It directs the U.S. Food and Drug Administration (FDA) to investigate how these particles affect human health and provide Congress with evidence-based recommendations to address any dangers.
Key Provisions
- Study Requirements: The Secretary of Health and Human Services, through the FDA Commissioner, must conduct a comprehensive study on microplastics exposure. This includes:
- Identifying the primary ways people come into contact with microplastics (e.g., through eating contaminated food or drinking water).
- Examining health effects on specific areas, such as:
- Children's health.
- The endocrine system (hormone-regulating body system).
- Cancer risk.
- Chronic illnesses (long-term health conditions).
- Reproductive health.
- Covering any other relevant health topics deemed important by the FDA.
- Reporting Mandate: Within one year of the law's enactment, the FDA must submit a detailed report to Congress. The report will include:
- Key findings and conclusions from the study.
- Suggestions for new laws or agency actions to reduce health risks from microplastics in food and water.
Significant Changes to Existing Law
This bill introduces a new federal requirement for the FDA to specifically study and report on microplastics in food and water. Previously, no dedicated U.S. law mandated such a focused investigation, though the FDA already regulates food and water safety under broader authorities like the Federal Food, Drug, and Cosmetic Act. This adds a targeted research obligation without altering core FDA powers.
Potential Impacts
- On Government Agencies: The FDA will need to allocate resources (staff, funding, and expertise) for the study, potentially straining budgets unless Congress provides additional appropriations. The report could lead to new FDA guidelines or enforcement actions on food and water contamination.
- On Citizens: It may increase public awareness of microplastic risks, particularly for vulnerable groups like children and those with chronic conditions. Long-term, it could result in safer food and water standards, reducing exposure and related health issues.
- On International Relations: Minimal direct impact, but findings could influence U.S. participation in global efforts to curb plastic pollution (e.g., through treaties like the UN's plastics treaty negotiations), potentially pressuring trading partners to align on safety standards.
Main Stakeholders Affected
- Government Entities: U.S. Department of Health and Human Services (HHS) and FDA (directly responsible for the study); Congress (receives the report and may act on recommendations).
- Public and Health Groups: Consumers, especially families with young children, patients with endocrine or reproductive issues, and environmental health advocates who could benefit from informed protections.
- Industry and Businesses: Food producers, water suppliers, and packaging manufacturers, who may face future regulations based on the study's outcomes.
- Researchers and Scientists: Academic and private experts in toxicology and environmental science, who could contribute to or build on the FDA's work.
Notable Legal, Constitutional, or Political Implications
- Legal: The bill leverages Congress's authority under the Constitution (Article I) to oversee federal agencies and promote public welfare. It creates an enforceable deadline for the FDA report, with potential for judicial review if unmet, but includes flexibility for the agency to define study scope.
- Constitutional: Aligns with the government's role in protecting public health (a implied power under the Commerce Clause), without infringing on individual rights or states' authorities.
- Political: Highlights bipartisan concern (introduced by Senators from different parties) over emerging environmental threats. It could spark debates on plastic regulation, funding priorities, and the balance between innovation in industries like packaging and public safety, potentially influencing future environmental legislation.
This summary was generated by AI and may contain inaccuracies. Refer to the official source document for the authoritative text.
Sponsor
Cosponsors (3)
Sen. Scott, Rick [R-FL], Sen. Blunt Rochester, Lisa [D-DE], Sen. Moody, Ashley [R-FL]
Recent Actions
- 2025-07-17: Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
- 2025-07-17: Introduced in Senate
Bill Versions
- Microplastics Safety Act — issued 2025-07-17 — PDF (3 pages)